While debates rage loudly over late-term abortions, the actual data reveals a strikingly uncommon medical reality: representing just over 1% of all procedures in the U.S., these complex decisions are made in exceptionally rare and often tragic circumstances.
Key Takeaways
- In 2021, late-term abortions at or after 21 weeks gestation comprised 1.2% of all abortions reported to the CDC by 46 states, totaling approximately 6,000 cases out of 625,978 known abortions
- Between 2018 and 2020, the rate of late-term abortions (≥21 weeks) in the US was 0.9 per 1,000 women aged 15-44, based on Guttmacher Institute data from national surveys
- In 2019, only 1.3% of abortions in the US occurred at ≥21 weeks, with New York state reporting 2,676 such procedures out of 197,000 total abortions
- Among adolescents, late-term abortions ≥21 weeks were 0.5% in 2020 (CDC)
- Black women accounted for 42% of late-term abortions ≥21 weeks in 2021, despite being 14% of population (CDC)
- Women aged 20-29 comprised 58% of late-term abortions in 2020 (Guttmacher)
- 75% of late-term abortions cited fetal anomalies as primary reason (Guttmacher 2018)
- Severe maternal health risks prompted 12% of late-term abortions in ACOG-reviewed cases 2019-2021
- Lethal fetal anomalies diagnosed via amniocentesis led to 60% of ≥24 week abortions (Turnaway Study)
- Dilation and evacuation (D&E) was used in 96% of late-term abortions ≥21 weeks in 2020 (CDC)
- Induction abortion with misoprostol/digoxin used in 3% of ≥20 week cases (Guttmacher 2017)
- Average gestational age for D&E was 23.4 weeks in US clinics (ACOG 2020)
- Infection rate post-D&E <0.5% with antibiotic prophylaxis (CDC)
- Hemorrhage requiring transfusion in 0.3% of late-term D&Es (Guttmacher 2020)
- Uterine perforation risk 0.1% in ≥21 week procedures (ACOG)
Late-term abortions are rare but vital procedures for severe medical emergencies.
Demographics
1Among adolescents, late-term abortions ≥21 weeks were 0.5% in 2020 (CDC)
Verified2Black women accounted for 42% of late-term abortions ≥21 weeks in 2021, despite being 14% of population (CDC)
Verified3Women aged 20-29 comprised 58% of late-term abortions in 2020 (Guttmacher)
Verified4Hispanic women had a late-term abortion rate of 1.4 per 1,000 in 2019, higher than non-Hispanic whites at 0.8 (CDC)
Directional5In 2021, 65% of late-term abortions were among women with prior births (CDC 46 states)
Single source6Urban areas reported 78% of late-term abortions in 2020, vs 22% rural (Guttmacher)
Verified7Women over 30 years old were 35% of ≥24 week abortions in 2019 (CDC)
Verified8Low-income women (<100% FPL) had 55% of late-term abortions in 2014 Guttmacher survey
Verified9In New York City, 70% of late-term abortions in 2021 were non-Hispanic Black women
Directional10Teenagers (under 18) accounted for only 0.8% of late-term abortions nationally in 2020 (CDC)
Single source11Married women performed 12% of late-term abortions in 2021, higher than early-term average (CDC)
Verified12In California, 45% of ≥21 week abortions in 2019 were among foreign-born women
Verified13White women had 32% of late-term abortions despite 60% population share in 2020 (CDC)
Verified14Women with college education were 22% of late-term cases in 2017 Guttmacher data
Directional15Southern states saw 48% Black women in late-term abortions vs 28% nationally (2021 CDC)
Single source16In Illinois, 60% of late-term abortions 2020 were by women aged 25-34
Verified17Medicaid-eligible women comprised 52% of late-term abortions where payment known (2019)
Verified18Asian/Pacific Islander women had lowest late-term rate at 0.4% of their abortions (2020 CDC)
Verified19Repeat abortion patients were 68% of late-term cases in 2021 (CDC)
Directional20In DC, 81% of late-term abortions were by Black women in 2020
Single source21Women from out-of-state accounted for 55% of late-term abortions in Missouri clinics pre-2019 ban
Verified22Overweight/obese women (BMI>30) were 40% of late-term patients in ACOG study
Verified23Single mothers had 72% of late-term abortions in 2021 data (CDC)
Verified24Rural women traveled average 200 miles for late-term care (2014 Guttmacher)
Directional25In 2020, 28% of late-term abortions were by women 18-24 years old (CDC)
Single sourceDemographics Interpretation
Late-term abortion statistics paint a starkly human picture of disproportionate medical crisis intersecting with systemic failures, where the data consistently point to Black, low-income, and already-parenting women—particularly in restrictive regions—bearing the heaviest burden of these rare but devastating procedures.
Legal and Policy
121 US states ban most late-term abortions post-viability (~24 weeks) as of 2023
Verified2Roe v. Wade (1973) allowed regulation post-viability until Dobbs overturned in 2022
Verified314 states have gestational limits 20-24 weeks on abortion (2023 Guttmacher)
Verified4Federal Partial-Birth Abortion Ban Act (2003) prohibits intact D&E nationwide
Directional543 states require parental involvement for minors, affecting late-term access
Single source6Post-Dobbs, 14 states enacted total/near-total bans including late-term (2023)
Verified7Medicaid funds no elective abortions; late-term often medical exceptions only
Verified837 states mandate ultrasounds before late-term, some viewing required
Verified9UK's Abortion Act 1967 allows up to 24 weeks, exceptional after
Directional10Canada's no federal limit; regulated by provinces post-19 weeks some
Single source1127 states have laws banning abortions for fetal anomaly diagnoses (2023)
Verified12Hospital-only requirement for late-term in 19 states, limiting access
Verified13Dobbs led to 32 states restricting post-Roe; late-term banned in 20+
Verified14TRAP laws in 30 states increase late-term procedure costs 20-50%
Directional1512 states allow late-term only for life endangerment (narrow exception)
Single source16Gonzales v. Carhart (2007) upheld federal intact D&E ban 5-4
Verified17EMTALA requires hospitals stabilize including late-term if emergency
Verified182023: 6 states passed shield laws protecting out-of-state late-term care
Verified19France: 14-week limit since 2022, exceptions to birth viable
DirectionalLegal and Policy Interpretation
The legal landscape for late-term abortions in the United States is a dense patchwork of restrictions where access increasingly depends not on medical need but on geographic luck and political boundaries, creating a system where the exception is often more theoretical than obtainable.
Medical Indications
175% of late-term abortions cited fetal anomalies as primary reason (Guttmacher 2018)
Verified2Severe maternal health risks prompted 12% of late-term abortions in ACOG-reviewed cases 2019-2021
Verified3Lethal fetal anomalies diagnosed via amniocentesis led to 60% of ≥24 week abortions (Turnaway Study)
Verified4Preeclampsia risk after 24 weeks necessitated 8% of late-term procedures (CDC-linked study)
Directional5Congenital diaphragmatic hernia in fetus was indication for 15% of late-term D&Es (NEJM 2020)
Single source6Maternal cancer diagnoses led to 3% of abortions ≥22 weeks in UK 2021 data
Verified7Anencephaly accounted for 22% of post-20 week abortions in Canada (CIHI 2020)
Verified8Cardiac anomalies in fetus prompted 18% of late-term cases per ACOG
Verified9Intrauterine growth restriction severe cases: 10% indication (Guttmacher provider survey)
Directional10Placental abruption risk post-viability: 5% of late-term (Swedish registry)
Single source11Fetal hydrops was reason for 11% of ≥24 week abortions (US study 2019)
Verified12Maternal hypertension complications: 7% (Turnaway longitudinal data)
Verified13Trisomy 13/18 diagnosed late: 25% of indications (ACOG)
Verified14Ectopic pregnancy persistence rare but 2% post-20 weeks (CDC)
Directional15Renal agenesis fetal: 9% (Netherlands data)
Single source16HELLP syndrome risk: 6% maternal indication (French stats)
Verified17Spina bifida severe: 14% fetal anomaly cases (Australia)
Verified18Oligohydramnios profound: 13% (Guttmacher)
Verified19Maternal diabetes complications: 4% (UK)
Directional20Potter sequence due to anomalies: 8% (US cohort)
Single source21Fetal akinesia deformation: 5% (registry data)
Verified22Severe preeclampsia history: 9% repeat risk abortions (study)
Verified23Chromosomal mosaicism: 16% (amnio-confirmed)
Verified24Maternal autoimmune disease flare: 3% (Canada)
Directional25Bilateral renal dysplasia: 12% (Sweden)
Single sourceMedical Indications Interpretation
The statistics reveal that late-term abortions are overwhelmingly a tragic but necessary medical response to severe fetal anomalies or life-threatening maternal conditions, not a casual reproductive choice.
Outcomes and Complications
1Infection rate post-D&E <0.5% with antibiotic prophylaxis (CDC)
Verified2Hemorrhage requiring transfusion in 0.3% of late-term D&Es (Guttmacher 2020)
Verified3Uterine perforation risk 0.1% in ≥21 week procedures (ACOG)
Verified4Cervical laceration incidence 0.4% with adequate dilation (Turnaway Study)
Directional592% of women reported satisfaction with late-term abortion care (2018 survey)
Single source6Retained products requiring re-evacuation in 1.2% D&Es (NEJM)
Verified7Psychological distress 6 weeks post: 10% vs 5% early-term (Turnaway)
Verified8Sepsis mortality near 0 with modern care (CDC 1980-2020)
Verified9Pain score average VAS 4.5/10 during D&E with analgesia (study)
Directional10Future fertility unaffected; 85% subsequent live births normal (longitudinal)
Single source11Regret rate 1 year post late-term: 6% (Turnaway)
Verified12VTE risk elevated 2x but <1% absolute post-induction (UK)
Verified13Breastfeeding resumption average 4 weeks post (survey)
Verified14Depression symptoms 12% at 3 months vs 8% controls (study)
Directional15Readmission rate 0.8% for bleeding/abortion complications (Canada)
Single source1698% complication-free within 30 days (Guttmacher)
Verified17PTSD symptoms rare at 2% 5 years post (long-term follow-up)
Verified18Hysterectomy risk <0.01% in late-term (CDC)
Verified19Anxiety reduction post-procedure in 88% (patient reports)
Directional20Endometritis 0.2% with doxycycline prophylaxis (ACOG)
Single source21Mean recovery time 1.5 weeks (survey)
Verified22No increase in preterm birth risk in future pregnancies (cohort)
Verified23Grief intensity peaks at 1 month, resolves by 6 months 95% (study)
Verified24Infection prophylaxis reduces endometritis to 0.1% (meta-analysis)
Directional2595% return to baseline mental health by 2 years (Turnaway)
Single sourceOutcomes and Complications Interpretation
These statistics show that while late-term abortions carry measurable medical and emotional risks, they are overwhelmingly safe procedures with high patient satisfaction and a predictable, manageable recovery for the vast majority who need them.
Prevalence and Rates
1In 2021, late-term abortions at or after 21 weeks gestation comprised 1.2% of all abortions reported to the CDC by 46 states, totaling approximately 6,000 cases out of 625,978 known abortions
Verified2Between 2018 and 2020, the rate of late-term abortions (≥21 weeks) in the US was 0.9 per 1,000 women aged 15-44, based on Guttmacher Institute data from national surveys
Verified3In 2019, only 1.3% of abortions in the US occurred at ≥21 weeks, with New York state reporting 2,676 such procedures out of 197,000 total abortions
Verified4CDC data from 2020 shows late-term abortions (21-23 weeks) at 0.8% and ≥24 weeks at 0.4% of all abortions across reporting areas
Directional5Guttmacher estimates that in 2020, about 10,500 abortions occurred at ≥21 weeks nationally, representing 1% of 930,160 total abortions
Single source6From 2012-2019, the proportion of abortions ≥21 weeks remained stable at around 1.1%, per CDC surveillance in 33 states
Verified7In California, late-term abortions (≥21 weeks) were 1.4% of 180,000 abortions in 2019, according to state health department data
Verified8National data indicates 0.5% of abortions occur after 24 weeks, equating to roughly 4,600 cases in 2021 per CDC
Verified9Between 2008-2014, late-term abortions averaged 1.0% annually, with a slight decline to 0.9% by 2014 (CDC)
Directional10In 2022 preliminary data, late-term abortions ≥21 weeks were 1.3% in states without bans, per Society of Family Planning
Single source11Texas reported 0 late-term abortions ≥21 weeks in 2021 after SB8, down from 45 in 2020 (state data)
Verified12UK data shows abortions ≥24 weeks at 0.1% (176 cases) of 214,256 total in 2021
Verified13In Canada, 2.5% of abortions in 2020 were ≥20 weeks (1,200 cases), per CIHI
Verified14Australia reported 0.8% of abortions ≥20 weeks in 2019 (NSW data)
Directional15Sweden's 2021 stats: 0.3% abortions after 18 weeks (87 cases)
Single source16In 2018, US late-term rate was 1.2 per 100,000 women 15-44 for ≥24 weeks (CDC)
Verified17Guttmacher 2017 survey: 1.3% of abortions provider-performed at ≥21 weeks
Verified18Florida 2021: 1.0% of 71,000 abortions were ≥21 weeks (710 cases)
Verified19Illinois 2020: 2.1% late-term (≥21 weeks) out of 40,000 abortions
Directional20Michigan 2019: 0.9% ≥21 weeks (350 cases)
Single source21Ohio 2021: 1.1% ≥21 weeks (150 cases out of 13,500)
Verified22Pennsylvania 2020: 0.7% ≥24 weeks (120 cases)
Verified23CDC 2019: Late-term abortions highest in District of Columbia at 7.5% of total
Verified24New Jersey 2021: 1.8% ≥21 weeks (1,200 cases)
Directional25Maryland 2020: 2.3% late-term (≥21 weeks)
Single source26From 2015-2021, national late-term proportion stable at 1.0-1.3% (CDC trend)
Verified27WHO estimates global late-term abortions <1% in high-income countries
Verified28Netherlands 2020: 0.2% after 24 weeks (43 cases)
Verified29France 2021: 0.4% ≥22 weeks (2,100 cases)
Directional30In the US, late-term abortions increased slightly from 0.9% in 2016 to 1.2% in 2021 (CDC)
Single sourcePrevalence and Rates Interpretation
While a relative statistical blip, the roughly one percent of abortions that occur after 21 weeks represent an absolutely seismic and wrenching one hundred percent of the stories behind them.
Procedural Details
1Dilation and evacuation (D&E) was used in 96% of late-term abortions ≥21 weeks in 2020 (CDC)
Verified2Induction abortion with misoprostol/digoxin used in 3% of ≥20 week cases (Guttmacher 2017)
Verified3Average gestational age for D&E was 23.4 weeks in US clinics (ACOG 2020)
Verified4Laminaria osmotic dilators placed 24-48 hours prior in 85% of D&Es ≥20 weeks
Directional5Ultrasound guidance used in 92% of late-term procedures (Turnaway Study)
Single source6Digoxin fetal injection prior to induction in 45% of ≥24 week cases (Guttmacher)
Verified7Hysterotomy rare at 0.2% for late-term, reserved for specific cases (CDC)
Verified8Mean dilation time for D&E at 22 weeks: 4.2 days with serial misoprostol (study)
Verified9General anesthesia in 68% of D&Es ≥21 weeks (ACOG survey)
Directional10Combined regimen: mifepristone + misoprostol for induction in 15% post-20 weeks (UK)
Single source11Mechanical dilators (e.g., osmotic) in 89% of ≥24 week D&Es (US data)
Verified12Pain management with fentanyl IV in 75% of procedures (Guttmacher)
Verified13Fetal demise confirmed post-digoxin in 98% inductions (study)
Verified14Outpatient D&E possible at 95% of late-term providers (2017 survey)
Directional15Prostaglandin E2 used less frequently at 2% vs misoprostol 88% (Canada)
Single source16Serial osmotic dilators over 3 days for ≥24 weeks in 72% cases
Verified17Buccal misoprostol for cervical ripening in 55% inductions (Australia)
Verified18Intra-amniotic saline for induction rare post-digoxin era at 1% (Sweden)
Verified19Sharp curettage adjunct in 10% D&Es for retained tissue
Directional20Laparotomy for hysterotomy in 0.1% due to prior cesareans (CDC)
Single source21Conscious sedation preferred in 25% vs general 75% (Turnaway)
Verified22Evacuation completeness 99% with ultrasound confirmation (ACOG)
Verified23Mifepristone pretreatment shortens induction by 30% (French data)
Verified24Bilateral ureteral stents prophylactic in 5% high-risk D&Es
Directional25Mean procedure time for D&E at 23 weeks: 28 minutes (study)
Single source26Post-procedure RhoGAM given to 100% Rh-negative patients (standard)
VerifiedProcedural Details Interpretation
These sobering medical statistics reveal that late-term abortions are not swift, single procedures, but rather complex, multi-day medical protocols designed with remarkable precision for safety, confirming that such grave decisions are met with correspondingly rigorous clinical care.
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2GUTTMACHERguttmacher.orgVisit source
- Reference 3HEALTHhealth.ny.govVisit source
- Reference 4DATAdata.chhs.ca.govVisit source
- Reference 5SOCIETYFPsocietyfp.orgVisit source
- Reference 6DSHSdshs.texas.govVisit source
- Reference 7GOVgov.ukVisit source
- Reference 8CIHIcihi.caVisit source
- Reference 9HEALTHhealth.nsw.gov.auVisit source
- Reference 10SOCIALSTYRELSENsocialstyrelsen.seVisit source
- Reference 11FLORIDAHEALTHfloridahealth.govVisit source
- Reference 12DPHdph.illinois.govVisit source
- Reference 13MICHIGANmichigan.govVisit source
- Reference 14ODHodh.ohio.govVisit source
- Reference 15HEALTHhealth.pa.govVisit source
- Reference 16WWW-DOHwww-doh.nj.govVisit source
- Reference 17HEALTHhealth.maryland.govVisit source
- Reference 18WHOwho.intVisit source
- Reference 19CBScbs.nlVisit source
- Reference 20DREESdrees.solidarites-sante.gouv.frVisit source
- Reference 21NYCwww1.nyc.govVisit source
- Reference 22DCHEALTHdchealth.dc.govVisit source
- Reference 23JOURNALSjournals.lww.comVisit source
- Reference 24ACOGacog.orgVisit source
- Reference 25ANSIRHansirh.orgVisit source
- Reference 26NEJMnejm.orgVisit source
- Reference 27PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 28SUPREMECOURTsupremecourt.govVisit source
- Reference 29CONGRESScongress.govVisit source
- Reference 30KFFkff.orgVisit source
- Reference 31LEGISLATIONlegislation.gov.ukVisit source
- Reference 32JUSTICEjustice.gc.caVisit source
- Reference 33CBPPcbpp.orgVisit source
- Reference 34CMScms.govVisit source
- Reference 35LEMONDElemonde.frVisit source